Endovascular Today's Avatar

Endovascular Today

@evtoday.bsky.social

Covering minimally invasive vascular disease therapies and providing the latest clinical data, commentaries, and regulatory news.

151 Followers  |  49 Following  |  195 Posts  |  Joined: 19.11.2024  |  1.708

Latest posts by evtoday.bsky.social on Bluesky

Preview
Advancing PE Management - Endovascular Today It is without question an exciting time in the field of pulmonary embolism (PE), a serious and often life-threatening condition that has long been

Pulmonary embolism care is entering a new era, driven by innovation, multidisciplinary PERT teams, and stronger clinical evidence. This issue explores the breakthroughs, remaining challenges, and why the future of PE care has never been brighter. evtoday.com/articles/202...

10.02.2026 15:35 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Preview
Establishing Industry Relationships That Work for You and Your Patients - Endovascular Today Industry reps provide critical knowledge, training, and patient-focused resources that help enhance patient care.

Dr. Meryl S. Logan offers a practical guide to building industry relationships that strengthen education, resources, and patient care.
evtoday.com/articles/202...

10.02.2026 14:13 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Preview
What’s Your Advice on Getting Involved at the Society Level and in Public Health Initiatives? - Endovascular Today Strategies for getting started, staying engaged, and shaping the future of your specialty and community.

Advice on society and public health involvementβ€”from getting started to growing into leadership. With Drs. Sabeen Dhand, Jeniann A. Yi, Hafeez Hassan, Poonam Velagapudi, & Eri Fukaya
evtoday.com/articles/202...

03.02.2026 14:25 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Preview
Path to the Podium: Advice for Early Career Physicians - Endovascular Today Insights on how to refine your interests, strengthen your expertise, and step confidently onto the podium.

Drs. Merve Ozen and Parag J. Patel reflect on key steps along the path to the podiumβ€”refining interests, building expertise, and developing skills for presenting confidently
evtoday.com/articles/202...

27.01.2026 14:36 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Preview
Early Career Insights - Endovascular Today News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.

And, catch up on the full Early Career Insights series here: evtoday.com/resource/ear...

20.01.2026 14:00 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Preview
Early Career Insights Part 3 Issue - Endovascular Today News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.

πŸ”” Early Career Insights is back with a new issue! With tips on navigating industry relationships, engaging with societies, and presenting at the podium, this installment focuses on professional growth beyond clinical responsibilities.
evtoday.com/issues/2026-...

20.01.2026 13:59 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 1    πŸ“Œ 0
Preview
Boston Scientific to Acquire Penumbra - Endovascular Today January 15, 2026—Boston Scientific Corporation and Penumbra, Inc. announced that the companies have entered into a definitive agreement under wh

Boston Scientific to Acquire Penumbra evtoday.com/news/boston-...

15.01.2026 14:24 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Preview
Amplifi Vein Dilation System Gains FDA Breakthrough Device Designation - Endovascular Today January 14, 2026—Amplifi Vascular, Inc., a developer of solutions for hemodialysis vascular access, announced it has been granted Breakthrough D

Amplifi Vein Dilation System Gains FDA Breakthrough Device Designation
evtoday.com/news/amplifi...

14.01.2026 22:04 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Preview
PAD Performance and Quality Measures Issued by ACC and AHA - Endovascular Today January 8, 2026—The American College of Cardiology (ACC) and American Heart Association (AHA) have issued the “2026 ACC/AHA Clinical Perfo

PAD Performance and Quality Measures Issued by ACC and AHA
evtoday.com/news/pad-per...

09.01.2026 14:28 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Preview
Ceribell’s LVO Stroke Detection Monitor Receives FDA Breakthrough Device DesignationΒ  - Endovascular Today January 5, 2026—Ceribell, Inc. announced that the FDA has granted Breakthrough Device designation for its large vessel occlusion (LVO) stroke de

Ceribell’s LVO Stroke Detection Monitor Receives FDA Breakthrough Device Designation
evtoday.com/news/ceribel...

07.01.2026 17:42 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Preview
Gore Excluder TAMBE Introduced in Japan - Endovascular Today December 19, 2025—Gore & Associates G.K. in Minato-ku, Tokyo, Japan, announced the first clinical use in Japan of the Gore Excluder thoracoa

Gore Excluder TAMBE Introduced in Japan
evtoday.com/news/gore-ex...

19.12.2025 20:30 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Preview
Radiation Safety: Don’t Wait Until It’s Too Late - Endovascular Today Understanding the hazards of radiation and the importance of physical health in the endovascular suite and cath lab, and what seasoned interventionalists wish they had known and done sooner.

Learn from experts about the hazards of radiation and lead-related strain, and what to do now to protect your health and career long term. W/Drs. Melissa L. Kirkwood, Lakshmi A. Ratnam, Patrick Muck (@patrickmuckmd), & Kenneth Rosenfield (@krosenfieldMD
evtoday.com/articles/202...

16.12.2025 13:52 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Preview
ARISE III Trial of Gore Ascending Stent Graft Begins Enrollment - Endovascular Today December 15, 2025—Gore & Associates announced the first implantation of its investigational Gore Ascending Stent Graft in the ARISE III tria

ARISE III Trial of Gore Ascending Stent Graft Begins Enrollment
evtoday.com/news/arise-i...

15.12.2025 22:17 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Preview
Biocoat Becomes Surmodics Services & Technologies Division - Endovascular Today December 10, 2025—Biocoat, Inc. announced the formation of Surmodics Services & Technologies, a newly named division of Surmodics, Inc. that

Biocoat Becomes Surmodics Services & Technologies Division
evtoday.com/news/biocoat...

11.12.2025 15:17 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
SVS Issues Commentary on CREST-2 - Endovascular Today On behalf of the Society for Vascular Surgery (SVS), Ali AbuRahma, MD, Past President of SVS; Marc Schermerhorn, MD, Past Chair, SVS Document Oversigh

SVS Issues Commentary on CREST-2
evtoday.com/news/svs-iss...

09.12.2025 21:49 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Preview
PRINCIPIIS FIH Study Begins for Angiolutions A3 Shield System in Early Stage AAA - Endovascular Today December 3, 2025—Angiolutions announced that the first patient has been treated in a first-in-human (FIH) study evaluating the safety and effect

PRINCIPIIS FIH Study Begins for Angiolutions A3 Shield System in Early Stage AAA

03.12.2025 19:11 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Preview
Rampart Guardian Radiation Protection System Evaluated in EVAR Procedure - Endovascular Today December 3, 2025— Rampart IC, a developer of radiation shielding for interventional suites, announced new data on the reduction in radiation exp

Rampart Guardian Radiation Protection System Evaluated in EVAR Procedure

03.12.2025 15:42 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Preview
Joining a Multidisciplinary Networkβ€”It’s Never Too Early - Endovascular Today Insights from PERT/DVT, limb salvage, and aortic team members on effective networking that lasts longer than the launch meeting.

Insights from Drs. Daniel Troha, Aditya M. Sharma (@adityasharmamd), Yulanka Castro, Omar Sheikh, and Nathan L. Liang on joining multidisciplinary teams and how collaboration and trust improve care

02.12.2025 16:10 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Preview
Humacyte’s ATEV Evaluated After Long-Term Clinical Use - Endovascular Today November 24, 2025—Humacyte, Inc. announced that multiple presentations on the company’s acellular tissue-engineered vessel (ATEV) were del

Humacyte’s ATEV Evaluated After Long-Term Clinical Use

25.11.2025 16:48 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Preview
First Case Dos and Don’ts - Endovascular Today Experts share advice for junior colleagues before their first case, including basic keys to success and pitfall avoidance, what to watch for when observing a case, and questions to ask and when to ask...

Ace your first vascular case with tips from Drs. Pavan K. Kavali, Danielle Sutzko, and Trisha Roy on preparing effectively, working as a team, avoiding early pitfalls, asking the right questions, and building confidence.

25.11.2025 15:19 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Preview
Early Career Insights - Endovascular Today News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.

And, catch up on the full Early Career Insights series here:

20.11.2025 17:04 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Preview
Early Career Insights Part 2 Issue - Endovascular Today News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.

πŸ’‘The next Early Career Insights installment is live! From preparing for your first case to building multidisciplinary connections & prioritizing radiation safety/musculoskeletal health, this issue shows how to build a foundation for clinical excellence.

20.11.2025 17:04 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 1    πŸ“Œ 0
Preview
CANSCAN Trial Evaluates Semiautonomous Vascular Mapping With Vexev VxWave Imaging System - Endovascular Today November 19, 2025—Vexev and U.S. Renal Care announced the results of the CANSCAN feasibility trial, which provided evidence that Vexev’s V

CANSCAN Trial Evaluates Semiautonomous Vascular Mapping With Vexev VxWave Imaging System

20.11.2025 13:55 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Preview
Vesalio Aspiration Devices FDA Cleared for Peripheral and Neurovascular Thrombectomy - Endovascular Today November 18, 2025—Vesalio announced two FDA 510(k) clearances for its aspiration devices for peripheral and neurovascular applications, advancin

Vesalio Aspiration Devices FDA Cleared for Peripheral and Neurovascular Thrombectomy

19.11.2025 20:52 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Preview
RapidAI’s Rapid Aortic Solution Cleared by FDAΒ  - Endovascular Today November 18, 2025—RapidAI announced FDA clearance of Aortic Management, part of the company’s Rapid Aortic product, a clinical artificial

RapidAI’s Rapid Aortic Solution Cleared by FDA

19.11.2025 15:37 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Preview
ViTAA Medical’s AiORTA Plan Cleared by FDA - Endovascular Today November 12, 2025—ViTAA Medical Solutions Inc. announced that the FDA has granted 510(k) clearance for the company’s AiORTA Plan. Accor

ViTAA Medical’s AiORTA Plan Cleared by FDA

12.11.2025 21:45 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Preview
FORWARD PAD Results Presented for J&J’s Shockwave Javelin Peripheral IVL CatheterΒ  - Endovascular Today November 11, 2025—Johnson & Johnson MedTech announced the 1-year results from the FORWARD PAD study of its Shockwave Javelin peripheral intr

FORWARD PAD Results Presented for J&J’s Shockwave Javelin Peripheral IVL Catheter | #VIVA25

12.11.2025 13:53 β€” πŸ‘ 1    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Preview
Gore’s Viabahn Fortegra Venous Stent Evaluated in Deep Venous Iliocaval Obstruction - Endovascular Today November 7, 2025—Gore & Associates announced trial results evaluating the investigational Viabahn Fortegra venous stent for the treatment of

Gore’s Viabahn Fortegra Venous Stent Evaluated in Deep Venous Iliocaval Obstruction

07.11.2025 21:38 β€” πŸ‘ 1    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Preview
Efficacy Outcomes From AVG Cohort of WAVE Presented for Merit’s Wrapsody CIE - Endovascular Today November 3, 2025—Merit Medical Systems, Inc. announced 24-month efficacy outcomes from the nonrandomized arteriovenous graft (AVG) cohort of the

Efficacy Outcomes From AVG Cohort of WAVE Presented for Merit’s Wrapsody CIE | Presented at #TheVEINS25

06.11.2025 14:08 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Preview
POWER PAD II Data Presented for AVS Pulse IVL System - Endovascular Today November 4, 2025—Amplitude Vascular Systems (AVS) announced results from the first 95 patients treated in the POWER PAD II United States pivotal

POWER PAD II Data Presented for AVS Pulse IVL System

05.11.2025 14:28 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0

@evtoday is following 20 prominent accounts